Enovix closed at $2.40 on Nov 5, down 13.98%, 78.8% below its 52-week closing high. Volume of 9.2M shares was 0.84× its 20-day average (close to normal).
Split-adjusted performance: -5.9% over one month, -62.6% over six months, -78.4% over one year.
In the quarter ended Jul 5, 2026, revenue was $9.02M, up 20.8% from a year earlier, with a net margin of -477.2%.
Short interest was 57.5M shares at the Oct 15 settlement, up 8.3% from the prior report (30.2% of float, 6.8 days to cover).